Adaptive Support Ventilation in the Weaning of COPD
Adaptive Support Ventilation for Faster Weaning in COPD: A Randomized Controlled Trial
1 other identifier
interventional
97
1 country
1
Brief Summary
Adaptive support ventilation (ASV) is a closed loop ventilation mode that can act both as pressure support (PSV) and pressure controlled (PCV) ventilation. Weaning with ASV shows promising results mainly in post-cardiac surgery patients. The aim of this randomized controlled study was to test the hypothesis that weaning with ASV could reduce the weaning duration in patients with chronic obstructive pulmonary disease (COPD) when compared with PSV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Apr 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 31, 2009
CompletedFirst Posted
Study publicly available on registry
September 1, 2009
CompletedMay 27, 2010
September 1, 2009
1.1 years
August 31, 2009
May 26, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Weaning duration
Secondary Outcomes (2)
Weaning success
Length of stay in the ICU
Study Arms (2)
Pressure support ventilation
ACTIVE COMPARATORAdaptive support ventilation
ACTIVE COMPARATORInterventions
Chronic obstructive pulmonary disease patients under mechanical ventilation were randomized to adaptive or pressure support ventilation modes when they met the weaning criteria.
Eligibility Criteria
You may qualify if:
- Diagnosis of COPD
- On invasive mechanical ventilation for at least 24 hours because of hypoxemic and/or hypercapnic respiratory failure
You may not qualify if:
- Mechanical ventilation less then 24 hours (self extubation or death),
- Having a tracheotomy and
- COPD coexisted with severe cardiac or neurologic diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit
Izmir, 35210, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Cenk Kirakli, MD
Izmir Dr Suat Seren Chest Diseases and Chest Surgery Education and Research Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 31, 2009
First Posted
September 1, 2009
Study Start
April 1, 2007
Primary Completion
May 1, 2008
Study Completion
December 1, 2008
Last Updated
May 27, 2010
Record last verified: 2009-09